(Q54315609)

27 May 2018

title

Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study. (English)

1 reference

27 May 2018

author name string

Scism JL

1

1 reference

27 May 2018

Powers KM

2

1 reference

27 May 2018

Artru AA

3

1 reference

27 May 2018

Lewis L

4

1 reference

27 May 2018

Shen DD

5

1 reference

27 May 2018

language of work or name

English

0 references

publication date

1 November 2000

1 reference

27 May 2018

published in

Brain Research

1 reference

27 May 2018

volume

884

1 reference

27 May 2018

issue

1--2

1 reference

27 May 2018

page(s)

77-86

1 reference

27 May 2018

Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Interaction between probenecid and two lipid-soluble barbiturates in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Blood-brain barrier transport of valproic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Assessment of valproic acid serum-cerebrospinal fluid transport by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

An electroencephalographic processing algorithm specifically intended for analysis of cerebral electrical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

In vivo uptake of valproic acid into brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Mass transfer in brain dialysis devices--a new method for the estimation of extracellular amino acids concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Diurnal oscillations of CSF valproate in monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Simultaneous and continuous measurement of free concentration of valproate in blood and extracellular space of rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Mechanism of valproic acid uptake by isolated rat brain microvessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Transport of valproate and its effects on GABA uptake in astroglial primary culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Low and variable presence of valproic acid in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Human brain, plasma, and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Effect of probenecid on breathing movements and cerebral clearance of prostaglandin E2 in fetal sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

Comparison of valproate concentrations in human plasma, CSF and brain tissue after administration of different formulations of valproate or valpromide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

The extracellular concentration of the anti-epileptic drug valproate in the rat brain as determined with microdialysis and an automated HPLC procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902893-6

10.1016/S0006-8993(00)02893-6

7 January 2021

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018